Together, our results suggest that unveiling how VPS13B deficiency is linked to Cohen syndrome clinical features, with the ultimate goal of identifying therapeutic opportunities, requires analyzing not only primary defects at the Golgi but also subsequent cellular responses in disease-relevant tissues. The gene discussed is VPS13B; the disease is Cohen syndrome.